Vulnerabilities

Vulnerability · CVE-2026-39965

TypeBot is a chatbot builder tool.

Published May 22, 2026 · catalog updated Jul 23, 2026 · TypeBot is a chatbot

Check if you run it

No confirmed exploitation is on record for CVE-2026-39965. EPSS is 0.38%. Act only if a listed version of TypeBot is a chatbot is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (TypeBot is a chatbot).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High7.7
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.38%
Remediation
Advisory link
Affected products
See sources for product scope

TypeBot is a chatbot builder tool. Versions 3.15.2 and prior contain an SSRF via Open Redirect Bypass as the HTTP Request block and Code block validate the initial request URL via validateHttpReqUrl() to block private IPs and cloud metadata hostnames. However, the HTTP clients (ky and fetch) follow 302 redirects without re-validating the redirect destination. An authenticated user can point a bot block to an attacker-controlled server that responds with a redirect to an internal IP, causing the Typebot server to reach internal services. An authenticated Typebot user can reach AWS metadata (169.254.169.254), private subnets, and container-internal services. Exploitable to extract cloud IAM credentials or probe internal APIs inaccessible from the internet. This issue has been fixed in version 3.16.0.

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2026-39965

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-39965. EPSS is 0.38%. Act only if a listed version of TypeBot is a chatbot is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-918: Server-Side Request Forgery (SSRF). EPSS 0.38%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. May 22, 2026 · NIST NVD

    Detected

    TypeBot is a chatbot builder tool. Versions 3.15.2 and prior contain an SSRF via Open Redirect Bypass as the HTTP Request block and Code block validate the initial request URL via validateHttpReqUrl() to block private IPs and cloud metadata hostnames. However, the HTTP clients (ky and fetch) follow 302 redirects without re-validating the redirect destination. An authenticated user can point a bot

  2. Jul 23, 2026 · NIST NVD

    Updated

    TypeBot is a chatbot builder tool. Versions 3.15.2 and prior contain an SSRF via Open Redirect Bypass as the HTTP Request block and Code block validate the initial request URL via validateHttpReqUrl() to block private IPs and cloud metadata hostnames. However, the HTTP clients (ky and fetch) follow 302 redirects without re-validating the redirect destination. An authenticated user can point a bot

Sources

  • CVE.orgVulnerability recordCVE-2026-39965

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-39965

    30-day exploitation probability 0.4%

    first.org
  • NIST NVDVulnerability recordCVE-2026-39965

    TypeBot is a chatbot builder tool. Versions 3.15.2 and prior contain an SSRF via Open Redirect Bypass as the HTTP Request block and Code block validate the initial request URL via validateHttpReqUrl() to block private IPs and cloud metadata hostnames. However, the HTTP clients (k

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.